title: Personalized medicine in adult acute lymphoblastic leukemia.
authors.affiliation: Onkologikum Frankfurt am Museumsufer, Frankfurt, Germany dieter.hoelzer@onkologikum-frankfurt.de hoelzer@em.uni-frankfurt.de.
authors.forename: Dieter
authors.initials: D
authors.lastname: Hoelzer
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D000069439:Dasatinib / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D009570:Nitriles; D057285:Precision Medicine / Q000379:methods; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines; D012074:Remission Induction; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D014178:Translocation, Genetic; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; C581634:BCR-ABL1 fusion protein, human; D014408:Biomarkers, Tumor; D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; D014750:Vincristine; C540383:ruxolitinib; D016044:Fusion Proteins, bcr-abl; D001215:Asparaginase; D000069439:Dasatinib